Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | RU | 22 Jul 2020 | |
Melanoma | Phase 1 | RU | 22 Jul 2020 | |
Non-Small Cell Lung Cancer | Phase 1 | RU | 22 Jul 2020 | |
Renal Cell Carcinoma | Phase 1 | RU | 22 Jul 2020 |